Results 111 to 120 of about 1,670 (170)
Pharmacology Research &Perspectives, Volume 13, Issue 4, August 2025.
Ida Štimac +3 more
wiley +1 more source
Establishing a standardized therapeutic testing protocol for spinal muscular atrophy
Neurobiology of Disease, 2006 Several mice models have been created for spinal muscular atrophy (SMA); however, there is still no standard preclinical testing system for the disease.
Li-Kai Tsai +4 more
doaj
General Anesthesia Plus Muscle Relaxant in a Patient with Kugelberg Welander Disease: A Case Report
Archives of Anesthesia and Critical Care, 2015 Spinal muscular atrophies (SMAs) represent a rare group of inherited disorders that cause progressive degeneration of the anterior horn cells of the spinal cord. The exact cause of the degeneration is unknown. Loss of these cells results in a progressive
Ebrahim Espahbodi +6 more
doaj
Archives of Health Science and ResearchObjective: This study aimed to compare the mechanical properties of upper and lower extremities between children with spinal muscular atrophy types 1 and 2 and healthy peers.
Seval KUTLUTÜRK-YIKILMAZ +3 more
doaj +1 more source
Proximal spinal muscular atrophy: current orthopedic perspective
The Application of Clinical Genetics, 2013 Gerrit Haaker, Albert Fujak Department of Orthopaedic Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany Abstract: Spinal muscular atrophy (SMA) is a hereditary neuromuscular disease of lower motor neurons that is ...
Haaker G, Fujak A
doaj
A Rare Case Report on Distal Spinal Muscular Atrophy (SMA)
, 2016 Habibur Rahaman +3 more
openalex +2 more sources